Katarzyna Stachowicz, dr hab.

Katarzyna Stachowicz, dr hab.

+48 12 6623315
room 312

Achievements

  • Publications

Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.

Autorzy:

DOI: 10.1016/j.ejmech.2009.07.007
Date: 2009-11-01

The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.

Autorzy:

DOI: 10.1016/j.neuropharm.2009.06.005
Date: 2009-09-01

Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1.

Autorzy:

DOI: 10.1016/j.ejmech.2008.09.021
Date: 2009-04-01

Effects of South African traditional medicine in animal models for depression.

Autorzy:

DOI: 10.1016/j.jep.2008.08.030
Date: 2008-10-01

Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.

Autorzy:

DOI: 10.1016/j.neuropharm.2008.06.033
Date: 2008-09-01

Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission.

Autorzy:

DOI: 10.1097/fbp.0b013e32830cd839
Date: 2008-09-01

Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.

Autorzy:

DOI: 10.1016/j.neuropharm.2007.08.002
Date: 2007-11-01

Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.

Autorzy:

DOI: 10.1097/fbp.0b013e3282d28f9c
Date: 2007-09-01

Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.

Autorzy:

DOI: 10.1016/j.neuropharm.2006.08.002
Date: 2007-02-01

Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.

Autorzy:

DOI: 10.1016/j.ejphar.2006.09.064
Date: 2006-12-01

See also